Leuprolide clinical trials: 162 trials
Page 3 of 4
- Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
NCT00586898 · Phase 2 · Completed
Posted results
- A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers
NCT02807363 · Phase 2 · Completed
Posted results
- Insulin Resistance and Testosterone in Women
NCT00123110 · Phase 2 · Completed
Posted results
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
NCT00016913 · Phase 2 · Completed
Posted results
- Bipolar Androgen-based Therapy for Prostate Cancer (BAT)
NCT01750398 · Phase 2 · Completed
Posted results
- Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
NCT00283803 · Phase 2 · Completed
Posted results
- Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
NCT01377389 · Phase 2 · Terminated
Posted results
- Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00544830 · Phase 2 · Active, not recruiting
Posted results
- Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
NCT03298087 · Phase 2 · Completed
Posted results
- Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
NCT01642186 · Phase 2 · Completed
Posted results
- Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
NCT00669162 · Phase 1/2 · Completed
Posted results
- A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
NCT03043807 · Phase 2 · Completed
Posted results
- A Study of Definitive Therapy to Treat Prostate Cancer
NCT02716974 · Phase 2 · Completed
Posted results
- Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT03361735 · Phase 2 · Active, not recruiting
Posted results
- A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
NCT00275262 · Phase 2 · Terminated
Posted results
- Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
NCT01023061 · Phase 2 · Completed
Posted results
- Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
NCT03007732 · Phase 2 · Completed
Posted results
- Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
NCT04051320 · Phase 2 · Completed
Posted results
- Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
NCT00225420 · Phase 1/2 · Completed
Posted results
- Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
NCT02278185 · Phase 2 · Completed
Posted results
- Neoadjuvant Ipilimumab in Prostate Cancer
NCT01194271 · Phase 2 · Completed
Posted results
- Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT01343368 · Phase 2 · Terminated
Posted results
- Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
NCT00589472 · Phase 2 · Completed
Posted results
- Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
NCT00903162 · Phase 2 · Completed
Posted results
- Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00937768 · Phase 2 · Terminated
Posted results
- A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
NCT03572387 · Phase 2 · Completed
Posted results
- Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer
NCT02508636 · Phase 2 · Terminated
Posted results
- Neurobiology of Bulimia Nervosa
NCT04225221 · Phase 2 · Completed
Posted results
- Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
NCT01163084 · Phase 1/2 · Terminated
Posted results
- Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
NCT00683917 · Phase 2 · Terminated
Posted results
- A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
NCT03093272 · Phase 2 · Terminated
Posted results
- Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
NCT02064582 · Phase 2 · Completed
Posted results
- Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer
NCT00924807 · Phase 1/2 · Terminated
Posted results
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
NCT01531205 · Phase 2 · Terminated
Posted results
- Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
NCT00860158 · Phase 2 · Terminated
Posted results
- Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
NCT01458301 · Phase 2 · Completed
Linked paper with results
- A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
NCT01452685 · Phase 2 · Completed
Linked paper with results
- Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
NCT06225284 · Phase 2 · Recruiting
Linked paper with results
- Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
NCT04249154 · Phase 2 · Recruiting
Linked paper with results
- A Treatment Study for Premenstrual Syndrome (PMS)
NCT00001259 · Phase 1 · Completed
Posted results
- Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
NCT04760691 · Phase 1 · Completed
Posted results
- Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
NCT05617885 · Phase 1 · Terminated
Posted results
- Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
NCT01642732 · Phase 1 · Terminated
Posted results
- Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"
NCT02167893 · Phase not stated · Completed
Posted results
- Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"
NCT02134977 · Phase not stated · Completed
Posted results
- Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
NCT01081873 · Phase not stated · Completed
Posted results
- Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
NCT05701007 · Phase not stated · Completed
Posted results
- Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
NCT01078545 · Phase not stated · Completed
Posted results
- Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
NCT02154139 · Phase not stated · Completed
Posted results
- Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)
NCT01294371 · Phase not stated · Completed
Posted results